Statement of the APhA to the Subcommittee on Health United States Senate. 93rd Congress, 2nd session, Washington, D.C., July 22, 1974.
D001682:Biological Availability; D001702:Biopharmaceutics; D007880:Legislation, Drug; D004364:Pharmaceutical Preparations / Q000592:standards; D012957:Societies, Pharmaceutical; D014481:United States; D014486:United States Food and Drug Administration
D004364:Pharmaceutical Preparations